The Unrestricted Use of Sirolimus- and Paclitaxel-Eluting Stents Results in Better Clinical Outcomes During 6-Year Follow-Up Than Bare-Metal Stents-Reference-Cited by-同舟云学术

The Unrestricted Use of Sirolimus- and Paclitaxel-Eluting Stents Results in Better Clinical Outcomes During 6-Year Follow-Up Than Bare-Metal Stents

Published:2010-10 Issue:10 Volume:3 Page:1051-1058
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Simsek Cihan,Magro Michael,Boersma Eric,Onuma Yoshinobu,Nauta Sjoerd T.,Gaspersz Marcia P.,van der Giessen Willem J.,van Domburg Ron T.,Serruys Patrick W.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. Four-year clinical follow-up of the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital registry;Daemen;Am J Cardiol,2008

2. Two-year clinical follow-up of the unrestricted use of the paclitaxel-eluting stents compared to the sirolimus-eluting stent as part of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry;Daemen;EuroIntervention,2006

3. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial;Morice;J Am Coll Cardiol,2007

4. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery;Moses;N Engl J Med,2003

5. Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent);Ellis;J Am Coll Cardiol Intv,2009

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Endothelial Nitric Oxide Synthase and Angiotensin-Converting Enzyme Genes Polymorphism With In-Sent Restenosis of Bare Metal Stents vs Drug-Eluting Stents in Egyptians;Angiology;2023-12-01

2. The effects of clinical, laboratory, and angiographic factors on stent thrombosis and major adverse cardiac events in paclitaxel eluting stents;Sanamed;2023

3. Impact of Nonobstructive Left Main Coronary Artery Atherosclerosis on Long-Term Mortality;JACC: Cardiovascular Interventions;2022-11

4. Outcomes of Percutaneous Coronary Intervention in Patients With Acquired Immunosuppression;The American Journal of Cardiology;2022-05

5. Mortality and Paclitaxel-Coated Devices;Circulation;2020-06-09